Last reviewed · How we verify

NCT02451020

Acclimatization of Healthy Subjects During a Stay at 3200 m

Completed NA Last updated 30 October 2018
What this trial tests

NA trial testing Altitude exposure in Effects of High Altitude in 20 participants. Completed in 9 August 2015.

Timeline
8 June 2015
Primary endpoint
9 August 2015
9 August 2015

Quick facts

Lead sponsorUniversity of Zurich
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment20
Start date8 June 2015
Primary completion9 August 2015
Estimated completion9 August 2015
Sites1 location across Kyrgyzstan

Drugs / interventions tested

Conditions studied

Sponsor

University of Zurich

Who can join

Adults 20 to 75, any sex, with Effects of High Altitude. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study evaluates respiratory acclimatization in healthy lowlanders staying for 3 weeks at 3200 m.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Respiratory acclimatization and psychomotor performance after rapid ascent and during 3 weeks at 3,100 m-A prospective cohort study in healthy individuals.
    Muralt L, Lichtblau M, Aeschbacher SS, Bisang M, et al · · 2025 · cited 1× · PMID 40098820 · DOI 10.3389/fphys.2025.1530426
  2. Respiratory acclimatization and psychomotor performance after rapid ascent and during 3 weeks at 3100 m. A prospective cohort study in healthy
    Muralt L, Lichtblau M, Aeschbacher SS, Bisang M, et al · · 2024 · DOI 10.1101/2024.11.18.24317470

Verify or expand the search:

Other trials of Altitude exposure

Trials testing the same drug.

Other University of Zurich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02451020.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing